DPP-4 Inhibitor in Type 2 Diabetes Mellitus Patient with Non-Alcoholic Fatty Liver Disease: Achieving Two Goals at Once?

Endocrinol Metab (Seoul). 2022 Dec;37(6):858-860. doi: 10.3803/EnM.2022.605. Epub 2022 Dec 26.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / drug therapy
  • Dipeptidyl-Peptidase IV Inhibitors* / therapeutic use
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Non-alcoholic Fatty Liver Disease* / complications
  • Non-alcoholic Fatty Liver Disease* / drug therapy

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Hypoglycemic Agents